Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results show ...
Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PM-JAY) continues to provide free treatment for serious illnesses to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results